Adverse Reactions by Radiopharmaceuticals: Retrospective Analysis of the Portuguese National Pharmacovigilance System
Although the number of notifications is limited, these findings provide valuable insights into the types and frequencies of adverse reactions associated with radiopharmaceuticals used in Portugal between 2010 and 2023. The data highlight the importance of continued pharmacovigilance efforts to monitor the safety of these specialized medical products and inform clinical decision-making.
Authors
- Ana Martín‐Suárez (ORCID: https://orcid.org/0000-0002-8191-0465)
- Sara Martins (ORCID: https://orcid.org/0000-0002-2038-3577)
- Mariana Ferreira Rocha
- Ângelo Jesus (ORCID: https://orcid.org/0000-0003-3972-8253)
- Ricardo Andrade (ORCID: https://orcid.org/0000-0002-7435-4915)
Institutions
- Universidad de Salamanca (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Rede de Química e Tecnologia (PT)
- Polytechnic Institute of Porto (PT)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-02-23
- DOI
- https://doi.org/10.1177/10600280251316542
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Institute on Drug Abuse